Askal A Ali

Tuesday/Thursday. 10:00 a.m. -11:00 a. m.

PHA6220 Economic Evaluation of Pharmaceuticals We. 9:00 a.m. -10:50 a.m.
PHA6292 Comparative Effectiveness Evaluation Th. 1:05 p.m. -2:45 p.m.
PHA7979 Advanced Research (Supervised Research) We Fr. 1:00 p.m. -2:50 p.m.
PHA8980 Dissertation (Graduate Dissertation) Tu.Th. 2:50 p.m. 5:20 p.m.

---

---

Dr. Askal Ali, a holder of a Ph.D. in Health Outcomes Research and Pharmacoeconomics from Florida Agricultural and Mechanical University (FAMU), serves as an Associate Professor in the field of Economic, Social, and Administrative Pharmacy (ESAP) at FAMU. Her academic journey includes a B.A. from Bahir-Dar University and an M.A. from Eastern Illinois University, both in Economics. Dr. Ali joined the FAMU College of Pharmacy and Pharmaceutical Sciences Institute of Public Health (CoPPS, IPH) faculty in 2016. Within her capacity as an educator, Dr. Ali has delivered courses encompassing various levels, undergraduate, professional, and graduate, focusing on topics such as the economic evaluation of pharmaceuticals, advanced pharmacoeconomics, comparative effectiveness research, pharmacoepidemiology, and advanced research. Her teaching excellence has been recognized through the College Teacher of the Year awards, bestowed upon her in both 2017 and 2023. Over her tenure at FAMU, spanning seven years, Dr. Ali has been an influential mentor for Ph.D., Master's, undergraduate, and high school students. Beyond her educational roles, she has actively engaged with the university community, contributing her expertise as a member of committees like Assessment, Policy and Procedures, Professional Learners Conduct, and Community Engagement, all within the CoPPS, IPH.
Dr. Ali's research endeavors encompass a range of critical areas, including cancer screening and treatment, health disparities, comparative effectiveness research, pharmacoeconomics/health econometrics, decision modeling, evidence synthesis (including systematic reviews and meta-analyses), and observational data analysis. Her contributions have materialized in numerous peer-reviewed publications and successful grant acquisitions as both Principal Investigator and Co-Investigator. Her impact extends beyond the academic realm, as she has participated in NIH grant review committees and assumed roles in various professional organizations, lending her expertise to different ad hoc committees. Moreover, Dr. Ali has assumed editorial responsibilities as a guest editor for the Journal of Healthcare and serves as a reviewer for multiple esteemed peer-reviewed journals.

---

---

• Health Economics and Outcomes Research
  
• Real-wold data analysis
  
• Racial Disparity

---

---

---

---

• Associate professor. 2021-Present
  Florida A&M University, Tallahassee, FL
• Assistant Professor. 2016 -2021
  Florida A&M University, Tallahassee, FL

---

Dr. Ali has received funding as PI and Co-I from the following agencies:

• National Institutes of Health (NIH)
  
• Food and Drug Administration (FDA)
  
• National Institute on Minority Health and Health Disparities (NIMHD)
  
• PhRMA's Collaboration Actions to Research Equity (CAREs)
  
• Medical Marijuana Education and Research Initiative Internal Award

---

---

• Innovation and Value Initiative (IVI) 3rd place best paper winner . 2023
  
• CoPPS, IPH ESAP Division, 2022-2023
  
• CoPPS, IPH ESAP Division, 2017-2018

---

---

• PHA6807 Advanced Pharmacoepidemiology
• PHA6220 Economic Evaluation of Pharmaceuticals
  
• PHA6292 Comparative Effectiveness Evaluation
  
• PHA7979 Advanced Research (supervised Research)
  
• PHA7980 Dissertation Research (Graduate Research)
  
• PHA6938 Research Seminar
  
• PHA6259 Measurement of Health Outcomes
  
• PHA6260 Advanced study of Pharmacoeconomics
  
• PHA6907 Specific Problem of Pharmaceutical Sciences
  
• PHA5037 Population Based care III
  
• PHA5212 Evidenced-Based Medicine
  
• PHA4085 Principle of Pharmacoeconomics
  

---

---

• Google Scholar

• My Bibliography

• ISPOR Faculty Adviser